SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
-13.21%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$624M
AUM Growth
+$624M
(-3.7%)
Cap. Flow
+$58.5M
Cap. Flow
% of AUM
9.38%
Top 10 Holdings %
Top 10 Hldgs %
44.27%
Holding
87
New
22
Increased
22
Reduced
22
Closed
15
Top Buys
| 1 |
The Beauty Health Co
SKIN
|
$39.2M |
| 2 |
Organogenesis Holdings
ORGO
|
$13.4M |
| 3 |
AnaptysBio
ANAB
|
$13.1M |
| 4 |
CVS Health
CVS
|
$11.8M |
| 5 |
Tandem Diabetes Care
TNDM
|
$10.9M |
Top Sells
| 1 |
Illumina
ILMN
|
$21.8M |
| 2 |
OraSure Technologies
OSUR
|
$20.7M |
| 3 |
Hologic
HOLX
|
$17.3M |
| 4 |
Smith & Nephew
SNN
|
$12.3M |
| 5 |
Lantheus
LNTH
|
$8.13M |
Sector Composition
| 1 | Healthcare | 89.55% |
| 2 | Consumer Staples | 6.75% |
| 3 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $69.6M | 10.86% | 295,541 -10,309 | -3% | -$2.43M |
|
|
2
The Beauty Health Co
SKIN
$264M
| $42.1M | 6.57% | 3,276,037 +3,048,425 | +1,339% | +$39.2M |
|
|
3
Organogenesis Holdings
ORGO
$653M
| $25.8M | 4.02% | 5,286,167 +2,746,000 | +108% | +$13.4M |
|
4
Surmodics
SRDX
$487M
| $24.6M | 3.84% | 661,004 +102,564 | +18% | +$3.82M |
|
|
EDAP
5
EDAP TMS
EDAP
$84.5M
| $22.3M | 3.48% | 3,284,189 +135,580 | +4% | +$922K |
|
6
iRadimed
IRMD
$921M
| $21.1M | 3.29% | 620,765 +190,714 | +44% | +$6.47M |
|
|
7
CVS Health
CVS
$92.8B
| $20.3M | 3.17% | 219,400 +126,900 | +137% | +$11.8M |
|
|
THER
8
DELISTED
THERATECHNOLOGIES INC COM
THER
| $17.8M | 2.77% | 7,822,412 +130,330 | +2% | +$296K |
|
9
Arcellx
ACLX
$3.85B
| $16.4M | 2.57% | 909,739 -80,000 | -8% | -$1.45M |
|
10
Inspire Medical Systems
INSP
$2.77B
| $16.2M | 2.53% | 88,950 +41,050 | +86% | +$7.5M |
|
11
Krystal Biotech
KRYS
$4.27B
| $14.1M | 2.2% | 214,482 -74,855 | -26% | -$4.92M |
|
12
ESSA Pharma
EPIX
$11.4M
| $13.1M | 2.05% | 4,168,799 -55,000 | -1% | -$173K |
|
|
13
AnaptysBio
ANAB
$569M
| $13.1M | 2.04% | +643,575 | New | +$13.1M |
|
14
AngioDynamics
ANGO
$417M
| $13M | 2.02% | 670,000 -356,450 | -35% | -$6.9M |
|
|
DICE
15
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $12.7M | 1.98% | 815,740 -168,254 | -17% | -$2.61M |
|
16
Nurix Therapeutics
NRIX
$714M
| $12.6M | 1.97% | 994,492 -17,146 | -2% | -$217K |
|
|
APEN
17
DELISTED
Apollo Endosurgery, Inc.
APEN
| $11.9M | 1.86% | 3,268,948 +375,848 | +13% | +$1.37M |
|
18
Neuropace
NPCE
$303M
| $11.6M | 1.8% | 2,334,003 +10,000 | +0.4% | +$49.5K |
|
19
AstraZeneca
AZN
$248B
| $11.2M | 1.75% | 169,696 +57,000 | +51% | +$3.77M |
|
|
20
Tandem Diabetes Care
TNDM
$845M
| $10.9M | 1.7% | +183,800 | New | +$10.9M |
|
21
Viridian Therapeutics
VRDN
$1.5B
| $9.73M | 1.52% | 841,018 +751,018 | +834% | +$8.69M |
|
|
CUTR
22
DELISTED
Cutera, Inc.
CUTR
| $9.66M | 1.51% | +257,600 | New | +$9.66M |
|
23
Evolus
EOLS
$494M
| $9.4M | 1.47% | 810,676 -557,713 | -41% | -$6.47M |
|
24
BioAtla
BCAB
$26.7M
| $9.3M | 1.45% | 3,262,703 +747,279 | +30% | +$2.13M |
|
|
ISEE
25
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.8M | 1.37% | 914,346 -50,130 | -5% | -$482K |
|